In this article, we will take a detailed look at Jim Cramer Says You Should Avoid These 11 Stocks. For a quick overview of such stocks, read our article Jim Cramer Says You Should Avoid These 5 Stocks.
/PRNewswire/ The Human Insulin Drugs Market in Brazil report has been added to Technavio s offering. The human insulin drugs market in Brazil is estimated.
/PRNewswire/ The "Inhalers Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2023 Update".
Although the stock markets overall enjoyed a banner year in 2023 – the S&P 500 was up 24% – Valley-area stocks, with a few notable exceptions, had a far more modest year.
MannKind Corp. (MNKD) has sold a 1% royalty in net sales of Tyvaso DPI inhalation powder to Sagard Healthcare in exchange for up to $200 million, including the purchase price of $150 million and an additional potential milestone payment of up to $50 million.